vinblastine
Sign in to saveVinblastine, sold under the brand name Velban among others, is a chemotherapy medication, typically used with other medications, to treat a number of types of cancer. This includes Hodgkin's lymphoma, non-small-cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer. It is given by injection into a vein.
Key facts
- Drug.CAS_number
- 865-21-4
- Drug.legal_US
- Rx-only
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 460778829
- Drug.image
- Vinblastine2DCSD.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Vinblastine ball-and-stick.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Velban, Velbe, others
- Drug.MedlinePlus
- a682848
- Drug.DailyMedID
- Vinblastine
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- intravenous
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- CA01
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
via Wikipedia infobox
Article
8 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Isolation and synthesis
- History
- References
Vinblastine, sold under the brand name Velban among others, is a chemotherapy medication, typically used with other medications, to treat a number of types of cancer. This includes Hodgkin's lymphoma, non-small-cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer. It is given by injection into a vein.
Most people experience some side effects. Commonly it causes a change in sensation, constipation, weakness, loss of appetite, and headaches. Severe side effects include low blood cell counts and shortness of breath. It should not be given to people who have a current bacterial infection. Use during pregnancy will likely harm the baby. Vinblastine works by blocking cell division.